Cooley Achieves Top Marks in US and Global M&A and PE Rankings

New York – April 17, 2025 – Cooley’s global mergers and acquisitions and private equity practices were recognized based on their M&A and PE activity on Q1 league tables from Bloomberg, Mergermarket, and LSEG Data & Analytics. Cooley’s M&A and PE practices continue to dominate in public and private transactions in the US and globally – despite the unsettled market.

Cooley’s top rankings include:

• Bloomberg, which ranked the firm #2 on its US and global M&A league tables by deal count, #2 for US and global mid-market M&A by deal count, and #2 for US and global private equity deals by deal count.*
• Mergermarket, which ranked the firm #3 on its US M&A league table by deal count and #4 on its global M&A league table by deal count, as well as #3 for US and global private equity buyouts and #5 for global PE exits by deal count.
• LSEG, which ranked the firm #4 on its US and global M&A league tables for announced deals by deal count.

In 2025, Cooley handled transactions across a diverse range of industries while also maintaining its top position in technology and life sciences. The firm’s market-leading transactions include representing:

• The Boston Celtics and the Grousbeck family in their $6.1 billion agreement to sell the Celtics
• Poppi in its $1.95 billion sale to Pepsi
• EsoBiotec in its sale to AstraZeneca for up to $1 billion
• Alani Nu in its $1.8 billion sale to Celsius Holdings
• Lantheus in its acquisition of Evergreen Theragnostics for up to $1 billion
• Araris Biotech in its sale to Taiho Pharmaceutical for up to $1.14 billion
• Chimerix in its $935 million sale to Jazz Pharmaceuticals
• Alumis in its all-stock merger with ACELYRIN
• Kim Kardashian in connection with SKIMS’ acquisition of SKKN by Kim
• DataStax in its sale to IBM
• LegalZoom in its acquisition of Formation Nation
• UiPath in its acquisition of Peak
• H1 in its acquisition of Ribbon Health
• Tenable in its $150 million acquisition of Vulcan Cyber
• MongoDB in its acquisition of Voyage AI
• PetLab Co. in the sale of its majority stake to BC Partners
• Egnyte in its strategic growth investment from GI Partners and TA Associates
• Drata in its acquisition of SafeBase
• Takara Bio in its acquisition of Curio Bioscience

Since 2020, Cooley’s world-class transactional team has worked on 1,600+ M&A deals for an aggregate value of more than $735 billion – guiding top public and private companies, financial advisors, and private equity sponsors in some of the market’s largest and most complex transactions. The M&A and PE groups include 180+ practitioners in major business and technology centers worldwide, representing all categories of participants in transactions.

* The Bloomberg platform data has not been published by Bloomberg.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.